Global Acne Treatment Market: By Product Type (Antibiotics, Retinoid Therapy, Hormonal Drugs, Anti-Inflammatory Drugs, Chemical Peels, Radiofrequency Devices and Laser Devices), By Medication Type (Prescription and OTC) By Acne Type (Inflammatory Acne and Non-Inflammatory Acne), By Route of Administration (Oral, Topical, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores, and Retail Stores) and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

August 2017 | 205 pages | ID: G91ED10CF93EN
Precision Business Insights (PBI)

Abstracts

Global Acne Treatment Market Report Description:

Acne treatment market report gives comprehensive outlook on acne treatment options across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report on acne treatment market gives historical, current, and future market sizes (US$ Mn) of product types, medication type, acne types, route of administration, distribution channels, and geographic regions. This report studies acne treatment market dynamics elaborately to identify the current trends & drivers, future market opportunities and possible challenges to the key stakeholders operating in the market. In addition, acne treatment market report includes recent product launches, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the acne treatment market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the acne treatment market report include suppliers, manufacturers, marketers, engaged in manufacturing and supply of acne treatment products.

Global Acne Treatment Market:

The Global acne treatment market estimated to be valued US$ 5,145 Mn in 2017 and poised to grow at CAGR of 5.0% over 2017 to 2023. Market for acne treatment products projected to reach US$ 6,896 Mn by 2023 owing to rise in prevalence of acne across the global and increase in disposable income.

Increasing burden of acne among young population

The change in life style of millennial and Gen X populations has changed the societal habits of young population, which is considered as the factor for early onset of acne among young population. The early onset of acne in younger population prompts the patients to seek the various treatments for acne that in turn increases the demand for acne treatment product in the market. Moreover, psychological effects associated with acne such as anxiety and depression in young patient pool is expected to create demand for OTC acne products over the forecast period. Several publications noted that psychological burden is very high among acne sufferers, which has created better market opportunity for market players across the globe.

Rise in disposable income and acne awareness expected to drive the market

The rise in disposable income and out-of-pocket healthcare expenditure in several developing and developed economies has created the market demand for acne treatment products across the globe. Increase in disposable income has prompted the patients to seek better treatment options for acne and several other diseases. Moreover, the rise in acne awareness among young population owing to targeted marketing campaigns by several multinational players is expected to drive acne treatment market over the forecast period.

North America leads the market with higher revenue share in global acne treatment market

North America leads the global acne treatment market in terms of revenue in 2016 and projected to remain dominant across the forecast period owing to availability of various treatment options and awareness among the young population. Asia Pacific presented better growth opportunities for the market players owing to availability of large pool of young population who seek better treatment for acne.

COMPETITION ASSESSMENT

Key players profiles in the global acne treatment market include:

• GlaxoSmithKline plc (Stiefel Laboratories Inc.) (U.K)
• Nestlé (Galderma S.A.) (Switzerland)
• Valeant Pharmaceutical International, Inc. (Canada)
• Johnson and Johnson (U.S)
• Allergan plc. (Ireland)
• Cipher Pharmaceuticals Inc. (Canada)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Bayer AG (Germany)
• Others

Market players are focusing on mergers and acquisitions to improve their market position in acne treatment market. For instance, in 2014, Nestlé acquired Galderma S.A., a dermatology company, to strengthen market position. Moreover market players are lunching generic versions to gain larger market revenue share. For instance in July 2017, Teva launched generic version of Epiduo (adapalene and benzoyl peroxide) gel 0.1%/2.5% in the US for the treatment of acne.

KEY FINDINGS OF THE REPORT:

• Acne treatment market expanding at 5.0% CAGR over 2017 to 2023 to reach market value of US$ 6,896 Mn by 2023
• Based on acne type inflammatory acne accounted for larger market share in 2016 and projected to dominate throughout the forecast period
• Retinoid therapy is gaining traction in recent times owing to safety and efficacy and retinoid segment expected to emerge as larger revenue grossing sub-segment in acne treatment market
• Players focusing on expanding geographic presence to garner market opportunities in developing economies

KEY FEATURES OF THE REPORT:

• The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
• The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

DETAILED MARKET SEGMENTATION

By Product Type

• Antibiotics
• Retinoid Therapy
• Hormonal Drugs
• Anti-Inflammatory Drugs
• Chemical Peels
• Radiofrequency Devices
• Laser Devices

By Medication Type

• Prescription
• OTC

By Acne Type

• Inflammatory Acne
• Non-Inflammatory Acne

By Route of Administration

• Oral
• Topical
• Parenteral

By Distribution Channel

• Hospitals
• Clinics
• Retail Pharmacies
• Online Pharmacies
• Drug Stores
• Retail Stores

Geography

• North America
• U.S
• Canada
• Europe
• Germany
• France
• U.K
• Italy
• Spain
• Russia
• Poland
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia & New Zealand
• ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
• South Korea
• Rest of Asia-Pacific
• Latin America
• Brazil
• Mexico
• Argentina
• Venezuela
• Rest of Latin America
• Middle East and Africa (MEA)
• Gulf Cooperation Council (GCC) Countries
• Israel
• South Africa
• Rest of MEA

Contents

1. RESEARCH METHODOLOGY

1.1. Secondary and Primary research
  1.1.1. Secondary Sources
  1.1.2. Primary Sources
1.2. Market Revenue Estimation Methodology
1.3. Key Assumptions
1.4. Acronyms

2. SCOPE OF STUDY

2.1. Market Definition
2.2. Objective of the Research
2.3. Regions covered in the study

3. EXECUTIVE SUMMARY

4. GLOBAL ACNE TREATMENT MARKET DYNAMICS

4.1. Drivers
  4.1.1. Economic Drivers
  4.1.2. Demand Side Drivers
  4.1.3. Supply Side Drivers
4.2. Restraints
4.3. Opportunities/Unmet Needs of the Market
4.4. Trends

5. UNIQUE FEATURES OF THE REPORT

5.1. Competition analysis
5.2. Regulatory landscape
5.3. PESTLE analysis
5.4. Porter’s analysis

6. GLOBAL ACNE TREATMENT MARKET ANALYSIS, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Antibiotics
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.2. Retinoid Therapy
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.3. Hormonal Drugs
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.4. Anti-Inflammatory Drugs
  6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.5. Chemical Peels
  6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.6. Radiofrequency Devices
  6.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.7. Laser Devices
  6.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

7. GLOBAL ACNE TREATMENT MARKET ANALYSIS, BY MEDICATION TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Prescription
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2. OTC
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

8. GLOBAL ACNE TREATMENT MARKET FORECAST, BY ACNE TYPE ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. Inflammatory Acne
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.2. Non-Inflammatory Acne
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

9. GLOBAL ACNE TREATMENT MARKET FORECAST, BY ROUTE OF ADMINISTRATION ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

9.1. Oral
  9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.2. Topical
  9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.3. Parenteral
  9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

10. GLOBAL ACNE TREATMENT MARKET FORECAST, BY DISTRIBUTION CHANNEL ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

10.1. Hospitals
  10.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
10.2. Clinics
  10.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
10.3. Retail Pharmacies
  10.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
10.4. Online Pharmacies
  10.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
10.5. Drug Stores
  10.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
10.6. Retail Stores
  10.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  10.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

11. ACNE TREATMENT MARKET ANALYSIS, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

11.1. North America Acne Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
  11.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.1.1.1. Antibiotics
    11.1.1.2. Retinoid Therapy
    11.1.1.3. Hormonal Drugs
    11.1.1.4. Anti-Inflammatory Drugs
    11.1.1.5. Chemical Peels
    11.1.1.6. Radiofrequency Devices
    11.1.1.7. Laser Devices
  11.1.2. Medication Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.1.2.1. Prescription
    11.1.2.2. OTC
  11.1.3. Acne Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.1.3.1. Inflammatory Acne
    11.1.3.2. Non-Inflammatory Acne
  11.1.4. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.1.4.1. Oral
    11.1.4.2. Topical
    11.1.4.3. Parenteral
  11.1.5. Distribution Channel Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.1.5.1. Hospitals
    11.1.5.2. Clinics
    11.1.5.3. Retail Pharmacies
    11.1.5.4. Online Pharmacies
    11.1.5.5. Drug Stores
    11.1.5.6. Retail Stores
  11.1.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.1.6.1. U.S.
    11.1.6.2. Canada
11.2. Europe Acne Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
  11.2.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.2.1.1. Antibiotics
    11.2.1.2. Retinoid Therapy
    11.2.1.3. Hormonal Drugs
    11.2.1.4. Anti-Inflammatory Drugs
    11.2.1.5. Chemical Peels
    11.2.1.6. Radiofrequency Devices
    11.2.1.7. Laser Devices
  11.2.2. Medication Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.2.2.1. Prescription
    11.2.2.2. OTC
  11.2.3. Acne Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.2.3.1. Inflammatory Acne
    11.2.3.2. Non-Inflammatory Acne
  11.2.4. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.2.4.1. Oral
    11.2.4.2. Topical
    11.2.4.3. Parenteral
  11.2.5. Distribution Channel Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.2.5.1. Hospitals
    11.2.5.2. Clinics
    11.2.5.3. Retail Pharmacies
    11.2.5.4. Online Pharmacies
    11.2.5.5. Drug Stores
    11.2.5.6. Retail Stores
  11.2.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.2.6.1. U.K
    11.2.6.2. Germany
    11.2.6.3. France
    11.2.6.4. Italy
    11.2.6.5. Spain
    11.2.6.6. Russia
    11.2.6.7. Poland 11.2.6.8. Rest of Europe
11.3. Asia-Pacific Acne Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
  11.3.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.3.1.1. Antibiotics
    11.3.1.2. Retinoid Therapy
    11.3.1.3. Hormonal Drugs
    11.3.1.4. Anti-Inflammatory Drugs
    11.3.1.5. Chemical Peels
    11.3.1.6. Radiofrequency Devices
    11.3.1.7. Laser Devices
  11.3.2. Medication Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.3.2.1. Prescription
    11.3.2.2. OTC
  11.3.3. Acne Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.3.3.1. Inflammatory Acne
    11.3.3.2. Non-Inflammatory Acne
  11.3.4. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.3.4.1. Oral
    11.3.4.2. Topical
    11.3.4.3. Parenteral
  11.3.5. Distribution Channel Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.3.5.1. Hospitals
    11.3.5.2. Clinics
    11.3.5.3. Retail Pharmacies
    11.3.5.4. Online Pharmacies
    11.3.5.5. Drug Stores
    11.3.5.6. Retail Stores
  11.3.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.3.6.1. Japan
    11.3.6.2. China
    11.3.6.3. India
    11.3.6.4. ASEAN
    11.3.6.5. Australia & New Zealand 11.3.6.6. Rest of Asia-Pacific
11.4. Latin America Acne Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
  11.4.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.4.1.1. Antibiotics
    11.4.1.2. Retinoid Therapy
    11.4.1.3. Hormonal Drugs
    11.4.1.4. Anti-Inflammatory Drugs
    11.4.1.5. Chemical Peels
    11.4.1.6. Radiofrequency Devices
    11.4.1.7. Laser Devices
  11.4.2. Medication Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.4.2.1. Prescription
    11.4.2.2. OTC
  11.4.3. Acne Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.4.3.1. Inflammatory Acne
    11.4.3.2. Non-Inflammatory Acne
  11.4.4. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.4.4.1. Oral
    11.4.4.2. Topical
    11.4.4.3. Parenteral
  11.4.5. Distribution Channel Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.4.5.1. Hospitals
    11.4.5.2. Clinics
    11.4.5.3. Retail Pharmacies
    11.4.5.4. Online Pharmacies
    11.4.5.5. Drug Stores
    11.4.5.6. Retail Stores
  11.4.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.4.6.1. Brazil
    11.4.6.2. Mexico
    11.4.6.3. Argentina
    11.4.6.4. Venezuela
    11.4.6.5. Rest of Latin America
11.5. Middle East & Africa (MEA) Acne Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
  11.5.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.5.1.1. Antibiotics
    11.5.1.2. Retinoid Therapy
    11.5.1.3. Hormonal Drugs
    11.5.1.4. Anti-Inflammatory Drugs
    11.5.1.5. Chemical Peels
    11.5.1.6. Radiofrequency Devices
    11.5.1.7. Laser Devices
  11.5.2. Medication Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.5.2.1. Prescription
    11.5.2.2. OTC
  11.5.3. Acne Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.5.3.1. Inflammatory Acne
    11.5.3.2. Non-Inflammatory Acne
  11.5.4. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.5.4.1. Oral
    11.5.4.2. Topical
    11.5.4.3. Parenteral
  11.5.5. Distribution Channel Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.5.5.1. Hospitals
    11.5.5.2. Clinics
    11.5.5.3. Retail Pharmacies
    11.5.5.4. Online Pharmacies
    11.5.5.5. Drug Stores
    11.5.5.6. Retail Stores
  11.5.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    11.5.6.1. Gulf Cooperation Council (GCC) Countries
    11.5.6.2. Israel
    11.5.6.3. South Africa